Business

EU drugs regulator gives green light to J&J’s single-shot COVID-19 vaccine By Reuters

[ad_1]

© Reuters. Johnson & Johnson COVID-19 vaccine is administered in Bay Shore, NY

(Reuters) – The European Union’s drugs regulator on Thursday recommended conditionally approving Johnson & Johnson (NYSE:)’s single dose COVID-19 vaccine, as the bloc seeks to speed up a stuttering inoculation campaign and boost its supplies of vaccines.

The COVID-19 shot is the fourth to be endorsed for use in the EU after vaccines from Pfizer-BioNTech, AstraZeneca-Oxford University and Moderna (NASDAQ:), and is recommended for those over 18 years of age, the European Medicines agency (EMA) said.

The United States, Canada and Bahrain have also approved the shot. South Africa is carrying out an expedited review.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



[ad_2]

Akshit chaudhary

Hey i am Akshit a wordpress developer and website developer. I am CEO of two websites till now and still going on for my future goals in digital marketing. I love to travel thats all i want to do. I am not sheep of 9 to 5 job. THATS ALL FOLKS.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button